Chronic Disease
Datawatch Column
-
Chronic Disease
FDA OKs Lowering Age for Osia Cochlear Implant to 5 Years Old
Osia is a new category of bone conducting hearing devices that use digital, piezoelectric stimulation.Sam Brusco, Associate Editor 04.19.24
-
Chronic Disease | Diagnostics
Lumicell's Breast Cancer Visualization System Wins FDA Approval
LumiSystem allows scanning the breast cavity post-lumpectomy, in real-time, to detect and resect residual cancer.Sam Brusco, Associate Editor 04.19.24
-
Chronic Disease
AI-Assisted Breast Cancer Screening May Reduce Unnecessary Testing
Researchers use AI to help read mammograms to reduce follow-up testing without missing cancer cases.Rachel Klemovitch, Assistant Editor 04.11.24
-
Chronic Disease
Ricoh 3D and SimBioSys to Develop AI-Powered Personalized 3D-Printed Models
This initiative will explore technologies that have the potential to aid in the treatment of breast cancer.Rachel Klemovitch, Assistant Editor 04.11.24
-
Chronic Disease | Patient Monitoring
Biolinq Raises $58M for Intradermal Glucose Sensor Pivotal Trial
Biolinq’s wearable patch has an array of tiny, electrochemical sensors that measure glucose levels just below the skin's surface.Sam Brusco, Associate Editor 04.04.24
-
Chronic Disease | Patient Monitoring
MTD to Buy Ypsomed's Pen Needle, Blood Glucose Monitoring Businesses
The transaction’s close is expected in summer 2024.Sam Brusco, Associate Editor 03.27.24
-
Chronic Disease | Patient Monitoring
Discussing Diabetes Tech Trends with Thermo Fisher's PPD
MPO spoke to Mona Eskandarian, director of project management for general medicine and cardiovascular, for PPD, Thermo Fisher's clinical research business.Online Exclusives Sam Brusco, Associate Editor 03.26.24
-
Chronic Disease | Patient Monitoring
Asking Abbott Labs About Diabetes Technology
MPO recently spoke to a spokesperson from Abbott Laboratories about the company's technology.Online Exclusives Sam Brusco, Associate Editor 03.21.24
-
Chronic Disease | Patient Monitoring
Medtronic Muses on Diabetes Management Technologies
MPO recently spoke to Ali Dianaty, SVP of product innovation and operation at Medtronic Diabetes.Online Exclusives Sam Brusco, Associate Editor 03.20.24
-
Chronic Disease | Patient Monitoring
Examining Continuous Glucose Monitoring with Dexcom CEO Kevin Sayer
Dexcom recently revealed that Stelo, its new glucose sensor, has received FDA approval.Online Exclusives Sam Brusco, Associate Editor 03.20.24
-
Chronic Disease
Discussing Insulin Pump Technology with Tandem Diabetes
MPO spoke to Elizabeth Gasser, EVP and chief strategy officer at Tandem Diabetes Care.Online Exclusives Sam Brusco, Associate Editor 03.20.24
-
Chronic Disease
Vicore Receives FDA Breakthrough Device Designation for Almee Digital Therapy
Almee digital therapy addresses anxiety for patients with pulmonary fibrosis.Rachel Klemovitch, Assistant Editor 03.19.24
-
Chronic Disease
Sequel's twiist Automated Insulin Delivery System Wins FDA OK
twiist is the first drug delivery system that directly measures the volume and flow of insulin delivered with every micro-dose.Sam Brusco, Associate Editor 03.18.24
-
Chronic Disease | Digital Health
Welldoc's BlueStar Mobile App Earns EU Nod
The solution guides people through living with diabetes using personalized, AI-driven digital coaching and insightsSam Brusco, Associate Editor 03.18.24
-
Chronic Disease
Insulet's Omnipod 5 Outperforms Standard Insulin Pump Therapy
Data showed that using Omnipod 5 led to a 17.5% improvement in time in range.Sam Brusco, Associate Editor 03.08.24
-
Chronic Disease | Patient Monitoring
Abbott's Real-World Data Backs FreeStyle Libre CGM Use with GLP-1s
People with Type 2 diabetes had a greater HbA1c reduction when using GLP-1 drugs and FreeStyle Libre tech together.Sam Brusco, Associate Editor 03.06.24
-
Chronic Disease | Patient Monitoring
FDA Clears Dexcom's Stelo, the First Over-the-Counter CGM
Stelo offers an option for those who don’t have insurance coverage for CGM.Sam Brusco, Associate Editor 03.05.24
-
Chronic Disease
Varian's HyperSight Imaging OK'ed for TrueBeam & Edge Radiotherapy Systems
HyperSight allows acquisition of high-quality images during a daily course of radiation treatments.Sam Brusco, Associate Editor 02.29.24
-
Chronic Disease | Patient Monitoring
The Sweet Science of Diabetes Technology
Continuous glucose monitoring and insulin delivery technology is becoming smaller, smarter, and integrated to ease diabetes management burden.Sam Brusco, Associate Editor 02.28.24
-
Chronic Disease | Contract Manufacturing | Patient Monitoring
Glucotrack Chooses Cirtec Medical as Manufacturer for Implantable Continuous Blood Glucose Monitor
The duo will collaborate to finish development and manufacturing activities to support the implantable CBGM’s first-in-human studies.Sam Brusco, Associate Editor 02.28.24
